telmisartan has been researched along with Granulocytic Leukemia, Chronic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gust, R; Obexer, P; Salcher, S; Schoepf, AM | 3 |
| Gust, R; Hohn, V; Obexer, P; Salcher, S; Schoepf, AM; Veider, F | 1 |
4 other study(ies) available for telmisartan and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Overcoming imatinib resistance in chronic myelogenous leukemia cells using non-cytotoxic cell death modulators.
Topics: Animals; Antineoplastic Agents; Cell Death; Cell Proliferation; Cells, Cultured; Chlorocebus aethiops; COS Cells; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Therapy, Combination; Humans; Imatinib Mesylate; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Molecular Structure; PPAR gamma; Structure-Activity Relationship; Telmisartan | 2020 |
Identification and development of non-cytotoxic cell death modulators: Impact of sartans and derivatives on PPARĪ³ activation and on growth of imatinib-resistant chronic myelogenous leukemia cells.
Topics: Animals; Cell Death; Cell Proliferation; Chlorocebus aethiops; COS Cells; Drug Design; Drug Resistance, Neoplasm; Humans; Imatinib Mesylate; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; PPAR gamma; Structure-Activity Relationship; Telmisartan | 2020 |
Tackling resistance in chronic myeloid leukemia: Novel cell death modulators with improved efficacy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Chlorocebus aethiops; COS Cells; Drug Design; Drug Resistance, Neoplasm; Gene Expression Regulation; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Nitriles; Phosphorylation; PPAR gamma; STAT5 Transcription Factor; Telmisartan; Transcriptional Activation; Tumor Suppressor Proteins | 2021 |
Synthesis and Characterization of Telmisartan-Derived Cell Death Modulators to Circumvent Imatinib Resistance in Chronic Myeloid Leukemia.
Topics: Animals; Carbazoles; Cell Death; Chlorocebus aethiops; COS Cells; Drug Resistance, Neoplasm; Humans; Imatinib Mesylate; Indoles; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Molecular Structure; PPAR gamma; Structure-Activity Relationship; Telmisartan | 2020 |